Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia

Reference

• Shanafelt TD. Predicting clinical outcome in CLL: how and why. Hematology Am Soc Hematol Educ Program 2009; 2009:421 - 9; http://dx.doi.org/10.1182/asheducation-2009.1.421; PMID: 20008228
   PubMedGoogle Scholar
• Gribben JG. How I treat CLL up front. Blood 2010; 115:187 - 97; http://dx.doi.org/10.1182/blood-2009-08-207126; PMID: 19850738
   PubMed Web of Science ®Google Scholar
• Butler T, Gribben JG. Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia. Blood Rev 2010; 24:135 - 41; http://dx.doi.org/10.1016/j.blre.2010.03.004; PMID: 20398985
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F, Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?. J Clin Oncol 2008; 26:4497 - 503; http://dx.doi.org/10.1200/JCO.2007.15.4393; PMID: 18662968
   PubMed Web of Science ®Google Scholar
• Chiorazzi N, Ferrarini M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 2011; 117:1781 - 91; http://dx.doi.org/10.1182/blood-2010-07-155663; PMID: 21148333
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358:1148 - 59; http://dx.doi.org/10.1056/NEJMra072067; PMID: 18337604
   PubMed Web of Science ®Google Scholar
• Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 2007; 129:879 - 90; http://dx.doi.org/10.1016/j.cell.2007.03.043; PMID: 17540169
   PubMed Web of Science ®Google Scholar
• Liu TH, Raval A, Chen SS, Matkovic JJ, Byrd JC, Plass C. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res 2006; 66:653 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-05-3712; PMID: 16423993
   PubMed Web of Science ®Google Scholar
• Chen SS, Claus R, Lucas DM, Yu L, Qian J, Ruppert AS, et al. Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood 2011; 117:862 - 71; http://dx.doi.org/10.1182/blood-2010-05-284638; PMID: 21098398
   PubMed Web of Science ®Google Scholar
• Seeliger B, Wilop S, Osieka R, Galm O, Jost E. CpG island methylation patterns in chronic lymphocytic leukemia. Leuk Lymphoma 2009; 50:419 - 26; http://dx.doi.org/10.1080/10428190902756594; PMID: 19347729
   PubMed Web of Science ®Google Scholar
• Chantepie SP, Vaur D, Grunau C, Salaün V, Briand M, Parienti JJ, et al. ZAP-70 intron1 DNA methylation status: determination by pyrosequencing in B chronic lymphocytic leukemia. Leuk Res 2010; 34:800 - 8; http://dx.doi.org/10.1016/j.leukres.2009.10.018; PMID: 19944462
   PubMed Web of Science ®Google Scholar
• Corcoran M, Parker A, Orchard J, Davis Z, Wirtz M, Schmitz OJ, et al. ZAP-70 methylation status is associated with ZAP-70 expression status in chronic lymphocytic leukemia. Haematologica 2005; 90:1078 - 88; PMID: 16079107
   PubMed Web of Science ®Google Scholar
• Raval A, Lucas DM, Matkovic JJ, Bennett KL, Liyanarachchi S, Young DC, et al. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. J Clin Oncol 2005; 23:3877 - 85; http://dx.doi.org/10.1200/JCO.2005.02.196; PMID: 15809452
   PubMed Web of Science ®Google Scholar
• Chen SS, Raval A, Johnson AJ, Hertlein E, Liu TH, Jin VX, et al. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2009; 106:13433 - 8; http://dx.doi.org/10.1073/pnas.0906455106; PMID: 19666576
   PubMed Web of Science ®Google Scholar
• Rush LJ, Raval A, Funchain P, Johnson AJ, Smith L, Lucas DM, et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004; 64:2424 - 33; http://dx.doi.org/10.1158/0008-5472.CAN-03-2870; PMID: 15059895
   PubMed Web of Science ®Google Scholar
• Kanduri M, Cahill N, Göransson H, Enström C, Ryan F, Isaksson A, et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 2010; 115:296 - 305; http://dx.doi.org/10.1182/blood-2009-07-232868; PMID: 19897574
   PubMed Web of Science ®Google Scholar
• Rahmatpanah FB, Carstens S, Hooshmand SI, Welsh EC, Sjahputera O, Taylor KH, et al. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics 2009; 1:39 - 61; http://dx.doi.org/10.2217/epi.09.10; PMID: 20495622
   PubMed Web of Science ®Google Scholar
• Tong WG, Wierda WG, Lin E, Kuang SQ, Bekele BN, Estrov Z, et al. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics 2010; 5:499 - 508; http://dx.doi.org/10.4161/epi.5.6.12179; PMID: 20484983
   PubMedGoogle Scholar
• Strathdee G, Sim A, Parker A, Oscier D, Brown R. Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL. Leukemia 2006; 20:1326 - 9; http://dx.doi.org/10.1038/sj.leu.2404254; PMID: 16688227
   PubMed Web of Science ®Google Scholar
• Meissner A, Mikkelsen TS, Gu H, Wernig M, Hanna J, Sivachenko A, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008; 454:766 - 70; PMID: 18600261
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu J, Tian G, Li N, Li Q, Ye M, et al. The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol 2010; 8:e1000533; http://dx.doi.org/10.1371/journal.pbio.1000533; PMID: 21085693
   PubMed Web of Science ®Google Scholar
• Dunwell TL, Dickinson RE, Stankovic T, Dallol A, Weston V, Austen B, et al. Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia. Epigenetics 2009; 4:265 - 9; PMID: 19550140
   PubMed Web of Science ®Google Scholar
• Martin-Subero JI, Ammerpohl O, Bibikova M, Wickham-Garcia E, Agirre X, Alvarez S, et al. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 2009; 4:e6986; http://dx.doi.org/10.1371/journal.pone.0006986; PMID: 19750229
   PubMed Web of Science ®Google Scholar
• Chim CS, Pang R, Liang R. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia. J Clin Pathol 2008; 61:1214 - 9; http://dx.doi.org/10.1136/jcp.2008.060152; PMID: 18765431
   PubMed Web of Science ®Google Scholar
• Shaknovich R, Cerchietti L, Tsikitas L, Kormaksson M, De S, Figueroa ME, et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 2011; 118:3559 - 69; http://dx.doi.org/10.1182/blood-2011-06-357996; PMID: 21828137
   PubMed Web of Science ®Google Scholar
• Lu D, Zhao Y, Tawatao R, Cottam HB, Sen M, Leoni LM, et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2004; 101:3118 - 23; http://dx.doi.org/10.1073/pnas.0308648100; PMID: 14973184
   PubMed Web of Science ®Google Scholar
• Gutierrez A Jr., Tschumper RC, Wu X, Shanafelt TD, Eckel-Passow J, Huddleston PM 3rd, et al. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood 2010; 116:2975 - 83; http://dx.doi.org/10.1182/blood-2010-02-269878; PMID: 20595513
   PubMed Web of Science ®Google Scholar
• Topol L, Chen W, Song H, Day TF, Yang Y. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem 2009; 284:3323 - 33; http://dx.doi.org/10.1074/jbc.M808048200; PMID: 19047045
   PubMed Web of Science ®Google Scholar
• Leshchenko VV, Kuo PY, Shaknovich R, Yang DT, Gellen T, Petrich A, et al. Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood 2010; 116:1025 - 34; http://dx.doi.org/10.1182/blood-2009-12-257485; PMID: 20427703
   PubMed Web of Science ®Google Scholar
• Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010; 463:808 - 12; http://dx.doi.org/10.1038/nature08750; PMID: 20072126
   PubMed Web of Science ®Google Scholar
• Lapalombella R, Andritsos L, Liu Q, May SE, Browning R, Pham LV, et al. Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. Blood 2010; 115:2619 - 29; http://dx.doi.org/10.1182/blood-2009-09-242438; PMID: 19965642
   PubMed Web of Science ®Google Scholar
• Pham LV, Tamayo AT, Li C, Bueso-Ramos C, Ford RJ. An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas. Blood 2010; 116:3899 - 906; http://dx.doi.org/10.1182/blood-2009-12-257378; PMID: 20664054
   PubMed Web of Science ®Google Scholar
• Pham LV, Tamayo AT, Yoshimura LC, Lin-Lee YC, Ford RJ. Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 2005; 106:3940 - 7; http://dx.doi.org/10.1182/blood-2005-03-1167; PMID: 16099873
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Deb J, Patra AK, Thuy Pham DA, Chen W, Vaeth M, et al. NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling network. J Exp Med 2011; 208:823 - 39; http://dx.doi.org/10.1084/jem.20100945; PMID: 21464221
   PubMed Web of Science ®Google Scholar
• Muzio M, Apollonio B, Scielzo C, Frenquelli M, Vandoni I, Boussiotis V, et al. Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood 2008; 112:188 - 95; http://dx.doi.org/10.1182/blood-2007-09-111344; PMID: 18292287
   PubMed Web of Science ®Google Scholar
• Marafioti T, Pozzobon M, Hansmann M-L, Ventura R, Pileri SA, Roberton H, et al. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol 2005; 128:333 - 42; http://dx.doi.org/10.1111/j.1365-2141.2004.05313.x; PMID: 15667535
   PubMed Web of Science ®Google Scholar
• Gu H, Bock C, Mikkelsen TS, Jäger N, Smith ZD, Tomazou E, et al. Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods 2010; 7:133 - 6; http://dx.doi.org/10.1038/nmeth.1414; PMID: 20062050
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met 1995; 57:289 - 300
   Web of Science ®Google Scholar